Home › Trial NCT02407054
A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer
- Trial IDNCT02407054
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorEli Lilly and Company
- Enrollment142
- Start date2015-04-29
- ConditionsProstate Cancer Metastatic
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.